(4-(4-Methylpiperazine-1-carbonyl)phenyl)boronic acid

Catalog No. :
ACWSUM702
CAS No. :
374927-12-5
Molecular Formula :
C12H17BN2O3
Molecular Weight :
248.09

IUPAC Name:(4-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid

(4-(4-Methylpiperazine-1-carbonyl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-(4-Methylpiperazine-1-carbonyl)phenyl)boronic acid
IUPAC Name(4-(4-methylpiperazine-1-carbonyl)phenyl)boronic acid
Molecular FormulaC12H17BN2O3
Molecular Weight248.09
SMILESO=C(C1=CC=C(B(O)O)C=C1)N2CCN(C)CC2
InChI KeyILNVLRZFTJYYCF-UHFFFAOYSA-N
SynonymBoronic acid, [4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]- (9CI);(4-((4-METHYLPIPERAZIN-1-YL)CARBONYL)PHENYL)BORONIC ACID;Boronic acid, [4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-;B-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-Boronic acid;Boronic acid, B-[4-[(4-methyl-1-piperazinyl)carbonyl]phenyl]-
CAS No.374927-12-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWSUM702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. ACNIRT390 route compound structure diagram
    ACNIRT39014047-29-1 In Stock
  4. Then
  5. ACWSUM702 route product structure diagram
    ACWSUM702374927-12-5
Inquiry

2. ACWSUM702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJACD865 route compound structure diagram
    ACJACD86534352-59-5 In Stock
  2. Plus
  3. ACNIRT390 route compound structure diagram
    ACNIRT39014047-29-1 In Stock
  4. Then
  5. ACWSUM702 route product structure diagram
    ACWSUM702374927-12-5
Inquiry

Comments (0)